Complexity of the endovascular intervention and clinical outcomes in acute ischaemic stroke-authors' reply

The Lancet Neurology

Volumn 13, Issue 9, 2014, Pages 865-866

  Khatri, Pooja ^a   Yeatts, Sharon D ^a  

^a Dept of Neurology and Rehabilitation Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT;

BRAIN ANGIOGRAPHY; BRAIN ISCHEMIA; CORONARY REPERFUSION; ENDOVASCULAR SURGERY; HUMAN; LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SYMPTOM; TIME TO TREATMENT; TREATMENT DURATION; UNIVARIATE ANALYSIS; VASCULAR ACCESS; FIBRINOLYTIC THERAPY; NEUROENDOSCOPY; PHASE 3 CLINICAL TRIAL (TOPIC); REPERFUSION; CEREBROVASCULAR ACCIDENT; FEMALE; MALE; PROCEDURES;

BRAIN ISCHEMIA; ENDOVASCULAR PROCEDURES; FEMALE; HUMANS; MALE; REPERFUSION; STROKE;

EID: 84906097481     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(14)70175-9     Document Type: Letter

References (2)

1. Khatri P, Yeatts SD, Mazighi M, et al. Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. Lancet Neurol 2014, 13:567-574.
2. Wechsler LR, Roberts R, Furlan AJ, et al. Factors influencing outcome and treatment effect in PROACT II. Stroke 2003, 34:1224-1229.